1. Home
  2. Live Updates
  3. Adjuvant capital

Live Breaking News & Updates on Adjuvant capital

Stay informed with the latest breaking news from Adjuvant capital on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Adjuvant capital and stay connected to the pulse of your community

Companies To Watch Antiva Biosciences

Companies To Watch Antiva Biosciences
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.

Redwood-city , California , United-states , Japan , Americans , Antiva-biosciences , Karl-hostetler , Wayne-koberstein , Babson-college , University-of-california-at-san-diego , Ernst-young , Executive-editor

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Australia , Australian , Franz-werner-haas , Paul-wolfrom , Alexander-siebert , Nicola-forrest , Limmatech-biologics , Steve-burnell , Stefan-klotter , Trophic-communications , Impact-fund , Novo-holdings

LimmaTech Biologics Raises Additional $3M in Series A

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Switzerland , Limmatech-biologics , Franz-werner-haas , Novo-holdings , Impact-fund , Adjuvant-capital ,

Begbies to meet expectations; McBride shines

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
Begbies Traynor Group PLC - Manchester, England-based...

United-states , Austria , Idaho , Australia , Phoenix , Arizona , Romsey , Hampshire , United-kingdom , London , City-of , Canada

Evofem Biosciences Announces Financial Results for the Third Quarter of 2023

— On track to achieve third consecutive year of revenue growth –
— Third consecutive quarter of favorable sales and marketing expense as a percentage of net sales —
— Reduced loss from...

Evofem-phexxi , Amy-raskopf , Saundra-pelletier , Securities-exchange , Drug-administration , Evofem-biosciences-inc , Prnewswire-evofem-biosciences-inc , Fourth-amendment , Securities-purchase , Security-agreement , Abbreviated-new-drug-application , Adjuvant-capital

Sam Bankman-Fried's guilty verdict should be a lesson for us all

SBF’s enormous fraud was made possible with venture capital dollars.

Mumbai , Maharashtra , India , Arlington , Texas , United-states , Zurich , Züsz , Switzerland , France , Stanford , Leicestershire

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

SCHLIEREN / ZURICH, Switzerland--(BUSINESS WIRE)--Nov 2, 2023--

Zurich , Züsz , Switzerland , Elias-papatheodorou , Mike-sinclair , Veronica-gambillara-fonck , Pureos-bioventures , Gf-group , Vesalius-biocapital , Adjuvant-capital , Verve-ventures , Schroders-capital

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Developm

Series C led by Pureos BioventuresFinancing to support completion of a Phase II trial of AntiBKV and to prepare manufacturing of drug for Phase IIISCHLIEREN / ZURICH, Switzerland--(BUSINESS WIRE)--Memo Therapeutics AG (“MTx”), a late-stage biotech company developing best-in-class therapeutic antibodies, announced to...

Switzerland , Zurich , Züsz , Veronica-gambillara-fonck , Pureos-bioventures , Elias-papatheodorou , Mike-sinclair , Gf-group , Memo-therapeutics , Vesalius-biocapital , Adjuvant-capital , Verve-ventures

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Shanghai , China , Mumbai , Maharashtra , India , San-francisco , California , United-states , Wellington , New-zealand-general- , New-zealand , Copenhagen

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus | Vaccines

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus

Shanghai , China , Denmark , Hong-kong , Copenhagen , Køavn- , Wellington , New-zealand-general- , New-zealand , Uganda , United-kingdom , South-africa